scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1177/1534735405282361 |
P698 | PubMed publication ID | 16282504 |
P50 | author | Lynda G. Balneaves | Q39694526 |
P2093 | author name string | Heather S Boon | |
Marja J Verhoef | |||
Annette Vroegindewey | |||
P2860 | cites work | Use of complementary/alternative therapies by women with advanced-stage breast cancer | Q24799982 |
Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology | Q28140688 | ||
Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study | Q30310774 | ||
Risk communication in practice: the contribution of decision aids | Q30480202 | ||
Complementary and alternative medicine use among women with breast cancer | Q33706802 | ||
Use of alternative medicine by women with early-stage breast cancer | Q33863723 | ||
Use of unconventional methods of therapy by cancer patients in Pakistan | Q33905010 | ||
Alternative medicine and common errors of reasoning | Q33937398 | ||
Surveys of complementary and alternative medicine: Part II. Use of alternative and complementary cancer therapies | Q34300241 | ||
The prevalence of complementary/alternative medicine in cancer: a systematic review | Q34750935 | ||
Blending the boundaries: steps toward an integration of complementary and alternative medicine into mainstream practice | Q35076778 | ||
Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment | Q36886270 | ||
Cross sectional study of use of alternative medicines in Chinese cancer patients | Q38558984 | ||
Complementary and alternative medicine use by patients with cancer in Wales: a cross sectional survey. | Q39383206 | ||
Use of complementary and alternative medicine by chinese women with breast cancer | Q39683268 | ||
Alternative therapies used by women with breast cancer in four ethnic populations | Q41712088 | ||
The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study | Q43540051 | ||
Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan | Q44325107 | ||
Ethnic differences in complementary and alternative medicine use among cancer patients | Q44695540 | ||
Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. | Q47377622 | ||
Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway | Q47622593 | ||
Decision making related to complementary therapies: a process of regaining control | Q47647408 | ||
Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy | Q47687620 | ||
Alternative therapy use in neurologic diseases: use in brain tumor patients | Q48279729 | ||
Beyond convention: describing complementary therapy use by women living with breast cancer | Q48578098 | ||
Determinants of the use of complementary therapies by patients with cancer | Q50105998 | ||
Cancer patients use of nonproven therapy: a 5-year follow-up study. | Q50912149 | ||
Complementary therapy use among older cancer patients. | Q51089864 | ||
Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. | Q51953308 | ||
A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. | Q52890434 | ||
Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use. | Q52894558 | ||
Determinants of the degree of complementary and alternative medicine use among patients with cancer. | Q53404935 | ||
Prevalence of complementary therapy use by women with breast cancer | Q57239193 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systematic review | Q1504425 |
patient | Q181600 | ||
P304 | page(s) | 274-286 | |
P577 | publication date | 2005-12-01 | |
P1433 | published in | Integrative Cancer Therapies | Q15708568 |
P1476 | title | Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review | |
P478 | volume | 4 |
Q35110167 | A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial |
Q30357999 | A whole systems research approach to cancer care: why do we need it and how do we get started? |
Q35104975 | An international comparison of attitudes toward traditional and modern medicine in a chinese and an american clinic setting |
Q48537406 | An oncology mind-body medicine day care clinic: concept and case presentation |
Q34125820 | Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD. |
Q54702751 | Australian integrative oncology services: a mixed-method study exploring the views of cancer survivors. |
Q47888333 | Australian men with cancer practice complementary therapies (CTs) as a coping strategy |
Q57164300 | Cancer and Complementary Therapies: Current Trends in Survivors' Interest and Use |
Q57921647 | Cancer and complementary medicine: an international perspective |
Q36405687 | Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. |
Q64096805 | Cancer patients' use of complementary and alternative medicine in Sweden: a cross-sectional study |
Q35154949 | Cancer survivors' disclosure of complementary health approaches to physicians: the role of patient-centered communication |
Q37619652 | Characteristics associated with the use of complementary health approaches among long-term cancer survivors |
Q28546848 | Chinese herbal therapy and Western drug use, belief and adherence for hypertension management in the rural areas of Heilongjiang province, China |
Q40868314 | Complementary and Alternative Medicine Use Among Overweight and Obese Cancer Survivors in the United States |
Q36763496 | Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use. |
Q36884706 | Complementary and alternative medicine (CAM) and supportive care in cancer: a synopsis of research perspectives and contributions by an interdisciplinary team |
Q34218550 | Complementary and alternative medicine use among older Australian women--a qualitative analysis |
Q48065895 | Complementary and alternative medicine use among people with asthma and health-related quality of life |
Q34402006 | Complementary and alternative medicine use amongst Malaysian orthopaedic oncology patients |
Q59569098 | Complementary and alternative medicine: what the public want and how it may be delivered safely and effectively |
Q37801275 | Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies. |
Q45749220 | Complementary or alternative medicine in cancer care-myths and realities |
Q37836631 | Cultural resources for health participation: examining biomedicine, acupuncture, and massage therapy for HIV-related peripheral neuropathy |
Q26996800 | Decision-making about complementary and alternative medicine by cancer patients: integrative literature review |
Q51771563 | Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer. |
Q36014626 | Development and Validation of an Instrument for Measuring Attitudes and Beliefs about Complementary and Alternative Medicine (CAM) Use among Cancer Patients |
Q33526491 | Diagnoses and visit length in complementary and mainstream medicine |
Q47206742 | Diagnosis and treatment of malignant tumors using integrated traditional and western medicine: progress, challenges and reflections |
Q37388781 | Differences between older and younger cancer survivors in seeking cancer information and using complementary/alternative medicine |
Q46025254 | Doctor-patient communication and cancer patients' choice of alternative therapies as supplement or alternative to conventional care. |
Q33250591 | Does trust in health care influence the use of complementary and alternative medicine by chronically ill people? |
Q42831840 | Efficacy of antioxidants as a Complementary and Alternative Medicine (CAM) in combination with the chemotherapeutic agent doxorubicin |
Q33470690 | Evaluating complex health interventions: a critical analysis of the 'outcomes' concept |
Q38751545 | Experiences of aromatherapy massage among adult female cancer patients: A qualitative study |
Q33831283 | Feasibility of a patient-controlled cognitive-behavioral intervention for pain, fatigue, and sleep disturbance in cancer. |
Q40640913 | From the conventional to the alternative: exploring patients' pathways of cancer treatment and care |
Q36093374 | Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer. |
Q38806124 | Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand. |
Q37211025 | Herbs and other botanicals in cancer patient care |
Q36860341 | How do we evaluate outcome in an integrative oncology program? |
Q31118081 | How to summarise and report written qualitative data from patients: a method for use in cancer support care |
Q33399441 | Individualised and complex experiences of integrative cancer support care: combining qualitative and quantitative data |
Q30540577 | Individualised medicine from the perspectives of patients using complementary therapies: a meta-ethnography approach |
Q37441000 | Integrating complementary and alternative medicine into cancer care: Canadian oncology nurses' perspectives |
Q47992027 | Integrating mindfulness in supportive cancer care: a cohort study on a mindfulness-based day care clinic for cancer survivors |
Q34484294 | Integrative oncology for breast cancer patients: introduction of an expert-based model |
Q37393006 | Integrative oncology: best of both worlds-theoretical, practical, and research issues |
Q36758552 | Intentions to use hypnosis to control the side effects of cancer and its treatment |
Q81758641 | Introduction to section on integrative oncology |
Q44607780 | Introduction: Partnering to embrace the future of cancer survivorship research and care |
Q90664459 | Medicine is Patriarchal, But Alternative Medicine is Not the Answer |
Q38859187 | Mind-body medicine and lifestyle modification in supportive cancer care: A cohort study on a day care clinic program for cancer patients |
Q36665542 | Motivations for consulting complementary and alternative medicine practitioners: a comparison of consumers from 1997-8 and 2005 |
Q33803022 | Nurse and patient characteristics predict communication about complementary and alternative medicine |
Q48182108 | Open to Exploration? Association of Personality Factors With Complementary Therapy Use After Breast Cancer Treatment |
Q36860321 | Patient decision-making about complementary and alternative medicine in cancer management: context and process |
Q56980739 | Patients of an Interdisciplinary Cancer Treatment Center: Use of, Knowledge About, and Demand for CAM Treatment Options |
Q48064358 | Patterns of self-management practices undertaken by cancer survivors: variations in demographic factors |
Q88622412 | Perceptions, opinions and knowledge of pharmacists towards the use of complementary medicines by people living with cancer |
Q27022639 | Personal prayer in patients dealing with chronic illness: a review of the research literature |
Q35693053 | Pharmacists and Natural Health Products: A systematic analysis of professional responsibilities in Canada |
Q33329849 | Potential role of mind-body therapies in cancer survivorship |
Q43612361 | Predictors of use of complementary and alternative medicine by non-hodgkin lymphoma survivors and relationship to quality of life |
Q93023771 | Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients With Cancer and Cancer Survivors in the United States |
Q33817506 | Prevalence and correlates of complementary and alternative medicine use among diabetic patients in Beirut, Lebanon: a cross-sectional study |
Q36534783 | Prevalence and correlates of postdiagnosis initiation of complementary and alternative medicine among patients at a comprehensive cancer center. |
Q90527952 | Prevalence and predictors of mind-body medicine use among women diagnosed with gynecological cancer: Findings from the 2017 US National Health Interview Survey |
Q33861639 | Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study. |
Q35124788 | Public awareness, patterns of use and attitudes toward natural health products in Kuwait: a cross-sectional survey. |
Q36731675 | Pulled in or pushed out? Understanding the complexities of motivation for alternative therapies use in Ghana |
Q34969344 | Reasons why Thai patients with chronic kidney disease use or do not use herbal and dietary supplements. |
Q53894772 | Rethinking the evidence imperative: why patients choose complementary and alternative medicine. |
Q50992253 | Socio-demographic and medical correlates of the use of biologically based complementary and alternative medicines amongst recent Australian cancer survivors. |
Q39833057 | Spirituality and use of complementary therapies for cure in advanced cancer |
Q47716776 | Superstition but not distrust in the medical system predicts the use of complementary and alternative medicine in a group of patients with acute leukemia |
Q37270213 | Support service use and interest in support services among lung cancer patients |
Q48033338 | Surveys of Cancer Patients and Cancer Health Care Providers Regarding Complementary Therapy Use, Communication, and Information Needs |
Q36860337 | Talking to cancer patients about complementary therapies: is it the physician's responsibility? |
Q38719159 | Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB. |
Q42324406 | Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II. |
Q48056210 | The Efficacy of Traditional Chinese Herbal Medicine in the Treatment of EGFR Mutated Stage IV Pulmonary Adenocarcinoma Patients Who Received First-Line EGFR-TKI Treatment |
Q36078810 | The Feasibility and Acceptability of LISTEN for Loneliness |
Q37823030 | The experience of using complementary therapies after a diagnosis of cancer: a qualitative synthesis |
Q38810214 | The interplay between autophagy and apoptosis induced by tanshinone IIA in prostate cancer cells |
Q45780414 | The responsiveness, content validity, and convergent validity of the Measure Yourself Concerns and Wellbeing (MYCaW) patient-reported outcome measure |
Q43776635 | The role of complementary and alternative medicine (CAM) routines and rituals in men with cancer and their significant others (SOs): a qualitative investigation |
Q90319271 | The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia |
Q48191318 | The use of complementary and alternative medicine by patients attending a UK headache clinic |
Q54964766 | The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia. |
Q91894803 | Training oncology physicians to advise their patients on complementary and integrative medicine: An implementation study for a manual-guided consultation |
Q33886054 | Understanding CAM Natural Health Products: Implications of Use Among Cancer Patients and Survivors. |
Q61772737 | Understanding CAM Use in Lebanon: Findings from a National Survey |
Q37562491 | Unproven Therapies for Diabetes and Their Implications |
Q39774500 | Use of complementary and alternative medicine by cancer patients at a Montreal hospital |
Q33298686 | Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria |
Q51914135 | Use of complementary therapies during chemotherapy: influence of patients' satisfaction with treatment decision making and the treating oncologist. |
Q91773738 | What motivates new, established and long-term users of herbal medicine: is there more than push and pull? |
Q30409900 | Young women's experiences with complementary therapies during cancer described through illness blogs |
Search more.